Skip to main content

Autism clinical trials at UCSF

2 in progress, 1 open to eligible people

Showing trials for
  • ML-004 in Adolescents and Adults With Autism Spectrum Disorders (ASD)

    open to eligible people ages 12-45

    ML-004-002 is a multi-center, randomized, double-blind, parallel-group, placebo-controlled study that will enroll approximately 150 adolescent and adult subjects with ASD. The primary objective is to evaluate the efficacy of ML-004 compared with placebo in the improvement of social communication deficits in subjects with ASD.

    San Francisco, California and other locations

  • CM-AT for the Treatment of Children With Autism

    Sorry, in progress, not accepting new patients

    This is a Phase III, open label extension study evaluating the continued safety and efficacy of CM-AT in pediatric patients with autism with all levels of fecal chymotrypsin.

    San Francisco, California and other locations

Our lead scientists for Autism research studies include .

Last updated: